Joint Comments on Two NIH Exclusive Licenses to CAR Therapy to Vor Biopharma and Senti Bio

On June 15, 2020, Knowledge Ecology International (KEI) and the Union for Affordable Cancer Treatments (UACT) submitted joint comments to the National Institutes of Health regarding two prospective exclusive patent licenses: “Prospective Grant of an Exclusive Patent License: Development and… Continue Reading

KEI and UACT Comments Regarding NIH Exclusive License to Retargeted Therapeutics for Cancer Treatment

Update: The NIH sent a response to our comments, available here. The response fails to address the glaring lack of information available regarding Retargeted Therapeutics. On June 8, 2020, Knowledge Ecology International and the Union for Affordable Cancer Treatment (UACT)… Continue Reading

WHA73: Written statement of KEI – Agenda item 3 – Address by WHO Director-General devoted to the COVID-19 pandemic response in advance of the opening of the Health Assembly

KEI is an accredited non-state actor at the World Health Organization (WHO). This is our statement at the 73rd World Health Assembly. https://extranet.who.int/nonstateactorsstatements/meetingoutline/6 Knowledge Ecology International Meeting: Seventy-third World Health Assembly Written statements on COVID-19 pandemic The biggest question today… Continue Reading

14 May 2020 – The WHO Covid-19 Technology Pool: The solution to ensure global access to Covid-19 health technologies

Livestream here: https://www.youtube.com/watch?v=iNMpuQfH088 On 14 May 2020, Health Action International, Knowledge Ecology International, Medicines Law & Policy, Pharmaceutical Accountability Foundation, and Wemos will convene a briefing entitled: “The WHO Covid-19 Technology Pool: The solution to ensure global access to Covid-19… Continue Reading